Septerna (SEPN) Retained Earnings (2023 - 2026)
Septerna's quarterly Retained Earnings came in at -$569000.0 in Q1 2026, up 99.59% year-on-year from -$285079.9 in Q1 2025, and up 99.66% quarter-over-quarter from -$167.3 million in Q4 2025.
Septerna has reported Retained Earnings for 4 years, with the latest figure at -$569000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 99.59% year-over-year to -$569000.0; the trailing twelve-month figure through Mar 2026 stood at -$569000.0 (up 99.59% YoY), and the FY2025 full-year result was -$167.3 million, down 41.29% from the prior year.
- Retained Earnings for Q1 2026 stood at -$569000.0, up from -$167.3 million in the prior quarter.
- The five-year high for Retained Earnings was $375000.0 in Q3 2025, with the low at -$167.3 million in Q4 2025.
- Average Retained Earnings over 4 years is -$91.8 million, with a median of -$108.0 million recorded in 2024.
- Year-over-year, Retained Earnings slumped 154.15% in 2024 and soared 100.38% in 2025.
- Tracing SEPN's Retained Earnings over 4 years: stood at -$46.6 million in 2023, then tumbled by 154.15% to -$118.4 million in 2024, then sank by 41.29% to -$167.3 million in 2025, then jumped by 99.66% to -$569000.0 in 2026.
- The last three Retained Earnings figures came in at -$569000.0 (Q1 2026), -$167.3 million (Q4 2025), and $375000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | -569,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -569,000.00 |
| Dec 31, 2025 | -167.25 Mn |
| Sep 30, 2025 | 375,000.00 |
| Jun 30, 2025 | -164.69 Mn |
| Mar 31, 2025 | -139.85 Mn |
| Dec 31, 2024 | -118.37 Mn |
| Sep 30, 2024 | -97.70 Mn |
| Dec 31, 2023 | -46.58 Mn |